To Newsroom
Oriola-KD signs letter of intent with four pharmacy chains in Sweden on purchasing, warehousing and pharmacy distribution of OTC products and traded goods
9.5.2012
Oriola-KD Corporation Stock Exchange Release 9 May 2012 at 1:45 p.m. Oriola-KD's Swedish pharmaceutical wholesale business, Oriola AB has signed a letter of intent with Apoteksgruppen, DocMorris, Medstop and Vårdapoteket on purchasing, warehousing and pharmacy distribution of OTC and traded goods products. The pharmacy chains signing the letter of intent had a combined market share of some 25 percent of the Swedish pharmacy market in 2011.(KPMG report 01/2012) The target is to sign co-operation agreements with the pharmacy chains during the second quarter and to start the co-operation in the autumn of 2012. "The letter of intent with Apoteksgruppen, DocMorris, Medstop and Vårdapoteket on purchasing, warehousing and pharmacy distribution of OTC products and traded goods is a significant strategic step for Oriola-KD. We are extremely pleased with the upcoming co-operation with these pharmacy chains. We will continue our determined work for providing and developing high quality services for pharmaceutical companies and pharmacies in Sweden." Eero Hautaniemi, President & CEO, Oriola-KD Corporation. Oriola-KD Corporation Eero Hautaniemi President & CEO For additional information, please contact: Mr. Eero Hautaniemi President & CEO tel. +358 10 429 2109 email: eero.hautaniemi@oriola-kd.com Distribution: NASDAQ OMX Helsinki Ltd. Principal media Published by: Oriola-KD Corporation Corporate Communications Orionintie 5 FI-02200 Espoo www.oriola-kd.com [HUG#1610306]